Previous studies demonstrated that PD-1 expression is associated with disease progression in individuals with various tumors, and blockade of the immune checkpoint molecule PD-1/PD-L1 axis was shown to exert anti-tumor effects (41, 42). The gene discussed is PDCD1; the disease is neoplasm.